Aurora Enters the Black, Beats Wall St. Q3 Forecast by Three Cents | GenomeWeb

NEW YORK, Oct 23 - Aurora Biosciences said Monday its third-quarter net income totaled $1.4 million, or six cents a share on a diluted basis, compared with a net loss of $1.7 million, 10 cents a share, in the year ago period.

Earnings beat Wall Street’s expectations by three cents a share, based on a survey of five analysts conducted by First Call/Thomson Financial.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genetic link between birth weight and adult-onset diseases, and more.

Even with all the current enthusiasm for gene therapies, Tech Review cautions that they are mostly in the early stages of development.

DNA phenotyping puts a potential face to a suspect in a nearly 25-year-old murder, the AP reports.

Researchers discuss the need for antibody standards at a meeting, NPR reports.